Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shire appoints Susan Kilsby to succeed Matthew Emmens as chair

This article was originally published in Scrip

Executive Summary

Matthew Emmens is retiring as non-executive chairman of Shire, and is being replaced following Shire's AGM on 29 April 2014 by Susan Kilsby, chairman of Shire's audit, compliance and risk committee since May 2013. She will step down from her previous role at that time, to be replaced by Dominic Blakemore. Mr Emmens joined the company as its CEO in 2003, and became chairman in 2008. Ms Kilsby joined the Shire board as a non-executive director in September 2011 following a career in investment banking. She will also become a member of Shire's nomination committee with effect from 1 February 2014.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC024197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel